̽»¨¾«Ñ¡

The aim of our research is to identify molecular risk and health factors with the goal of improving diagnostics and treatment for ADHD, anorexia, bipolar disorder, depression and psychosis.

We investigate molecular markers and mechanisms of disease and treatment effects through genetic, epigenetic and biochemical analyses. Our studies have a particular focus on the interconnected processes of inflammation, metabolic dysregulation and mitochondrial activity. We mainly use clinical and population-based naturalistic cohorts, but also models in cells and mice. We also work in large international consortia for psychiatric genetics.

Vision

A better quality of life for people with mental illness.

Objectives of the group's overall operations

To increase knowledge of the molecular causes behind mental illness to improve treatment and preventive care. To implement our findings in care and society. To contribute with analysis platforms to collaborative partners to drive technological development in molecular psychiatry. To educate the next generation of researchers and clinics in molecular psychiatry.

KIGene Core Facility offer genetic analyses, covering Sanger DNA sequencing, gene expression and genotyping, as well as digital spatial profiling and epigenetic analysis mainly aiming at small to medium size projects.

KI Gene website